SHOX2 and lung cancer: Consistent with previous studies [14, 20], SHOX2 proved to be a highly sensitive indicator for the diagnosis of lung cancer, with higher levels of methylation observed in patients with SCLC (95.7%) and LUSC (92.5%) compared to patients with LUAC (67.3%).